Affymax, Inc. Stock Nasdaq
Equities
US00826A1097
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Financials (USD)
Sales 2012 | 94.37M | Sales 2013 | 1.37M | Capitalization | 29.24M |
---|---|---|---|---|---|
Net income 2012 | -93M | Net income 2013 | -14M | EV / Sales 2012 | 6.75 x |
Net cash position 2012 | 69.14M | Net cash position 2013 | 5.6M | EV / Sales 2013 | 17.3 x |
P/E ratio 2012 |
-7.39
x | P/E ratio 2013 |
-2.03
x | Employees | - |
Yield 2012 * |
-
| Yield 2013 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
+22.81% | 47.9B | |
+46.56% | 41.42B | |
-1.88% | 40.7B | |
-6.20% | 28.92B | |
+11.33% | 25.55B | |
-21.00% | 19.27B | |
-1.43% | 12.15B | |
+30.73% | 12.14B | |
-0.48% | 11.99B |